22Nw, LP insider trades
22Nw, LP has filed 15 Form 4s with the SEC that we hold, for Dirtt Environmental Solutions LTD (DRTT) (Director, 10% owner), Foster L B Co (FSTR) (10% owner), Culp INC (CULP) (10% owner) and Anebulo Pharmaceuticals, Inc. (ANEB) (Director, 10% owner). Across all of them we count 13 purchases worth $18.1M and 16 sales worth $5.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 16 sales ($5.3M). The largest single trade was a purchase of 3,593,000 shares of Dirtt Environmental Solutions LTD worth $14.3M, dated 2021-08-12. The first filing on our record is dated 2021-07-30 and the latest 2026-03-30.
Dirtt Environmental Solutions LTD (DRTT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-07-28 | P, purchase reported on Form 4 | 236,504 | $981.5K | 2021-07-30 | SEC |
| 2021-07-29 | P, purchase reported on Form 4 | 800 | $3.4K | 2021-07-30 | SEC |
| 2021-08-12 | P, purchase reported on Form 4 | 64,950 | $249.4K | 2021-08-12 | SEC |
| 2021-08-12 | P, purchase reported on Form 4 | 3,593,000 | $14.3M | 2021-08-12 | SEC |
| 2023-12-01 | P, purchase reported on Form 4 | 4,524,378 | $2.3M | 2023-12-01 | SEC |
Foster L B Co (FSTR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-11-11 | S, sale reported on Form 4 | 2,749 | $75.7K | 2025-11-13 | SEC |
| 2025-11-11 | S, sale reported on Form 4 | 4,813 | $135.6K | 2025-11-13 | SEC |
| 2025-11-12 | S, sale reported on Form 4 | 3,368 | $91.1K | 2025-11-13 | SEC |
| 2025-11-13 | S, sale reported on Form 4 | 1,600 | $43.2K | 2025-11-13 | SEC |
| 2025-11-21 | S, sale reported on Form 4 | 3,412 | $92.2K | 2025-11-25 | SEC |
| 2025-11-24 | S, sale reported on Form 4 | 27,003 | $724.8K | 2025-11-25 | SEC |
| 2025-11-25 | S, sale reported on Form 4 | 1,725 | $46.5K | 2025-11-25 | SEC |
| 2025-12-08 | S, sale reported on Form 4 | 9,765 | $266.4K | 2025-12-10 | SEC |
| 2025-12-09 | S, sale reported on Form 4 | 4,800 | $129.3K | 2025-12-10 | SEC |
| 2025-12-10 | S, sale reported on Form 4 | 11,248 | $301.8K | 2025-12-10 | SEC |
| 2026-03-23 | S, sale reported on Form 4 | 78,414 | $2.2M | 2026-03-25 | SEC |
| 2026-03-24 | S, sale reported on Form 4 | 25,889 | $729.8K | 2026-03-25 | SEC |
| 2026-03-25 | S, sale reported on Form 4 | 2,716 | $76.3K | 2026-03-25 | SEC |
| 2026-03-26 | S, sale reported on Form 4 | 8,968 | $251.3K | 2026-03-30 | SEC |
| 2026-03-27 | S, sale reported on Form 4 | 862 | $24.2K | 2026-03-30 | SEC |
| 2026-03-30 | S, sale reported on Form 4 | 1,887 | $52.9K | 2026-03-30 | SEC |
Culp INC (CULP)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-07-12 | P, purchase reported on Form 4 | 13,275 | $67.3K | 2024-07-16 | SEC |
| 2024-07-16 | P, purchase reported on Form 4 | 9,703 | $50.4K | 2024-07-16 | SEC |
| 2024-07-17 | P, purchase reported on Form 4 | 5,749 | $30.0K | 2024-07-19 | SEC |
| 2024-07-18 | P, purchase reported on Form 4 | 2,621 | $13.6K | 2024-07-19 | SEC |
| 2024-07-19 | P, purchase reported on Form 4 | 2,671 | $13.9K | 2024-07-19 | SEC |
| 2024-12-18 | P, purchase reported on Form 4 | 1,246 | $6.5K | 2024-12-20 | SEC |
| 2024-12-19 | P, purchase reported on Form 4 | 7,634 | $40.1K | 2024-12-20 | SEC |
| 2024-12-20 | P, purchase reported on Form 4 | 4,564 | $23.9K | 2024-12-20 | SEC |
Anebulo Pharmaceuticals, Inc. (ANEB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1694297) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
